189 related articles for article (PubMed ID: 35577770)
21. In Vivo Evidence for Serine Biosynthesis-Defined Sensitivity of Lung Metastasis, but Not of Primary Breast Tumors, to mTORC1 Inhibition.
Rinaldi G; Pranzini E; Van Elsen J; Broekaert D; Funk CM; Planque M; Doglioni G; Altea-Manzano P; Rossi M; Geldhof V; Teoh ST; Ross C; Hunter KW; Lunt SY; Grünewald TGP; Fendt SM
Mol Cell; 2021 Jan; 81(2):386-397.e7. PubMed ID: 33340488
[TBL] [Abstract][Full Text] [Related]
22. A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate.
Pacold ME; Brimacombe KR; Chan SH; Rohde JM; Lewis CA; Swier LJ; Possemato R; Chen WW; Sullivan LB; Fiske BP; Cho S; Freinkman E; Birsoy K; Abu-Remaileh M; Shaul YD; Liu CM; Zhou M; Koh MJ; Chung H; Davidson SM; Luengo A; Wang AQ; Xu X; Yasgar A; Liu L; Rai G; Westover KD; Vander Heiden MG; Shen M; Gray NS; Boxer MB; Sabatini DM
Nat Chem Biol; 2016 Jun; 12(6):452-8. PubMed ID: 27110680
[TBL] [Abstract][Full Text] [Related]
23. Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN-amplified neuroblastoma.
Arlt B; Zasada C; Baum K; Wuenschel J; Mastrobuoni G; Lodrini M; Astrahantseff K; Winkler A; Schulte JH; Finkler S; Forbes M; Hundsdoerfer P; Guergen D; Hoffmann J; Wolf J; Eggert A; Kempa S; Deubzer HE
Int J Cancer; 2021 Mar; 148(5):1219-1232. PubMed ID: 33284994
[TBL] [Abstract][Full Text] [Related]
24. Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis.
Taha-Mehlitz S; Bianco G; Coto-Llerena M; Kancherla V; Bantug GR; Gallon J; Ercan C; Panebianco F; Eppenberger-Castori S; von Strauss M; Staubli S; Bolli M; Peterli R; Matter MS; Terracciano LM; von Flüe M; Ng CKY; Soysal SD; Kollmar O; Piscuoglio S
Theranostics; 2021; 11(9):4011-4029. PubMed ID: 33754045
[No Abstract] [Full Text] [Related]
25. Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs.
Corominas-Faja B; Quirantes-Piné R; Oliveras-Ferraros C; Vazquez-Martin A; Cufí S; Martin-Castillo B; Micol V; Joven J; Segura-Carretero A; Menendez JA
Aging (Albany NY); 2012 Jul; 4(7):480-98. PubMed ID: 22837425
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1.
Singh R; Yadav V; Kumar S; Saini N
Sci Rep; 2015 Dec; 5():17454. PubMed ID: 26632252
[TBL] [Abstract][Full Text] [Related]
27. PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis.
Samanta D; Park Y; Andrabi SA; Shelton LM; Gilkes DM; Semenza GL
Cancer Res; 2016 Aug; 76(15):4430-42. PubMed ID: 27280394
[TBL] [Abstract][Full Text] [Related]
28. BMP4 inhibits the proliferation of breast cancer cells and induces an MMP-dependent migratory phenotype in MDA-MB-231 cells in 3D environment.
Ampuja M; Jokimäki R; Juuti-Uusitalo K; Rodriguez-Martinez A; Alarmo EL; Kallioniemi A
BMC Cancer; 2013 Sep; 13():429. PubMed ID: 24053318
[TBL] [Abstract][Full Text] [Related]
29. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
Lu J; Tan M; Cai Q
Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
[TBL] [Abstract][Full Text] [Related]
30. Co-expression of α9β1 integrin and VEGF-D confers lymphatic metastatic ability to a human breast cancer cell line MDA-MB-468LN.
Majumder M; Tutunea-Fatan E; Xin X; Rodriguez-Torres M; Torres-Garcia J; Wiebe R; Timoshenko AV; Bhattacharjee RN; Chambers AF; Lala PK
PLoS One; 2012; 7(4):e35094. PubMed ID: 22545097
[TBL] [Abstract][Full Text] [Related]
31. Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism.
Bonuccelli G; Tsirigos A; Whitaker-Menezes D; Pavlides S; Pestell RG; Chiavarina B; Frank PG; Flomenberg N; Howell A; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Cell Cycle; 2010 Sep; 9(17):3506-14. PubMed ID: 20818174
[TBL] [Abstract][Full Text] [Related]
32. Anillin regulates breast cancer cell migration, growth, and metastasis by non-canonical mechanisms involving control of cell stemness and differentiation.
Wang D; Naydenov NG; Dozmorov MG; Koblinski JE; Ivanov AI
Breast Cancer Res; 2020 Jan; 22(1):3. PubMed ID: 31910867
[TBL] [Abstract][Full Text] [Related]
33. Give it or take it: the flux of one-carbon in cancer cells.
Meiser J; Vazquez A
FEBS J; 2016 Oct; 283(20):3695-3704. PubMed ID: 27042806
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer.
Dekhne AS; Hou Z; Gangjee A; Matherly LH
Mol Cancer Ther; 2020 Nov; 19(11):2245-2255. PubMed ID: 32879053
[TBL] [Abstract][Full Text] [Related]
35. Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis.
Griss T; Vincent EE; Egnatchik R; Chen J; Ma EH; Faubert B; Viollet B; DeBerardinis RJ; Jones RG
PLoS Biol; 2015 Dec; 13(12):e1002309. PubMed ID: 26625127
[TBL] [Abstract][Full Text] [Related]
36. Mitochondrial dynamics regulates migration and invasion of breast cancer cells.
Zhao J; Zhang J; Yu M; Xie Y; Huang Y; Wolff DW; Abel PW; Tu Y
Oncogene; 2013 Oct; 32(40):4814-24. PubMed ID: 23128392
[TBL] [Abstract][Full Text] [Related]
37. Purine nucleotide depletion prompts cell migration by stimulating the serine synthesis pathway.
Soflaee MH; Kesavan R; Sahu U; Tasdogan A; Villa E; Djabari Z; Cai F; Tran DH; Vu HS; Ali ES; Rion H; O'Hara BP; Kelekar S; Hallett JH; Martin M; Mathews TP; Gao P; Asara JM; Manning BD; Ben-Sahra I; Hoxhaj G
Nat Commun; 2022 May; 13(1):2698. PubMed ID: 35577785
[TBL] [Abstract][Full Text] [Related]
38. p66ShcA functions as a contextual promoter of breast cancer metastasis.
Lewis K; Kiepas A; Hudson J; Senecal J; Ha JR; Voorand E; Annis MG; Sabourin V; Ahn R; La Selva R; Tabariès S; Hsu BE; Siegel MJ; Dankner M; Canedo EC; Lajoie M; Watson IR; Brown CM; Siegel PM; Ursini-Siegel J
Breast Cancer Res; 2020 Jan; 22(1):7. PubMed ID: 31941526
[TBL] [Abstract][Full Text] [Related]
39. NAF-1 and mitoNEET are central to human breast cancer proliferation by maintaining mitochondrial homeostasis and promoting tumor growth.
Sohn YS; Tamir S; Song L; Michaeli D; Matouk I; Conlan AR; Harir Y; Holt SH; Shulaev V; Paddock ML; Hochberg A; Cabanchick IZ; Onuchic JN; Jennings PA; Nechushtai R; Mittler R
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14676-81. PubMed ID: 23959881
[TBL] [Abstract][Full Text] [Related]
40. Bardoxolone-methyl inhibits migration and metabolism in MCF7 cells.
Refaat A; Pararasa C; Arif M; Brown JE; Carmichael A; Ali SS; Sakurai H; Griffiths HR
Free Radic Res; 2017 Feb; 51(2):211-221. PubMed ID: 28277986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
